Controlled release of paclitaxel from a self-assembling peptide hydrogel formed in situ and antitumor study in vitro
Name
Liu-2011-Controlled release of.pdf
Size
3.37 MB
Format
Adobe PDF
Checksum (MD5)
116e9c91016ed21779d8c9c751a3886d
Author(s)
Liu, Jingping
Zhang, Lanlan
Yang, Zehong
Zhao, Xiaojun
Date Issued
September 2011
Journal
International Journal of Nanomedicine
Publisher
Dove Medical Press
Citation
Liu, Jingping, Lanlan Zhang, Zehong Yang, and Xiaojun Zhao. “Controlled Release of Paclitaxel from a Self-Assembling Peptide Hydrogel Formed in Situ and Antitumor Study in Vitro.” International Journal of Nanomedicine (September 2011): 2143.
Version
Final published version
Abstract
Background: A nanoscale injectable in situ-forming hydrogel drug delivery system was developed in this study. The system was based on a self-assembling peptide RADA16 solution, which can spontaneously form a hydrogel rapidly under physiological conditions. We used the RADA16 hydrogel for the controlled release of paclitaxel (PTX), a hydrophobic antitumor drug.
Methods: The RADA16-PTX suspension was prepared simply by magnetic stirring, followed by atomic force microscopy, circular dichroism analysis, dynamic light scattering, rheological analysis, an in vitro release assay, and a cell viability test.
Results: The results indicated that RADA16 and PTX can interact with each other and that the amphiphilic peptide was able to stabilize hydrophobic drugs in aqueous solution. The particle size of PTX was markedly decreased in the RADA16 solution compared with its size in water. The RADA16-PTX suspension could form a hydrogel in culture medium, and the elasticity of the hydrogel showed a positive correlation with peptide concentration. In vitro release measurements indicated that hydrogels with a higher peptide concentration had a longer half-release time. The RADA16-PTX hydrogel could effectively inhibit the growth of the breast cancer cell line, MDA-MB-435S, in vitro, and hydrogels with higher peptide concentrations were more effective at inhibiting tumor cell proliferation. The RADA16-PTX hydrogel was effective at controlling the release of PTX and inhibiting tumor cell growth in vitro.
Conclusion: Self-assembling peptide hydrogels may work well as a system for drug delivery.
MIT Department
Massachusetts Institute of Technology. Center for Biomedical Engineering
Terms of Use
Creative Commons Attribution-Noncommercial
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.2147/IJN.S24038
